Hussien, Y <br/><br/>
Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.  [electronic resource] 

 -  Journal of neuroimmunology  Dec 2001 
 - 102-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/s0165-5728(01)00432-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Antigens, CD--analysis<br/>Antigens, CD1--analysis<br/>B7-2 Antigen<br/>Cell Differentiation--drug effects<br/>Dendritic Cells--chemistry<br/>Drug Synergism<br/>Female<br/>Flow Cytometry<br/>Glatiramer Acetate<br/>Humans<br/>Immunophenotyping<br/>Interferon-beta--administration & dosage<br/>Interleukin-10--analysis<br/>Interleukin-12--analysis<br/>Male<br/>Membrane Glycoproteins--analysis<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--drug therapy<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Peptides--administration & dosage<br/>Receptors, Interleukin-3--analysis<br/>Th2 Cells--cytology